by Cardiovascular Research Foundation Credit: Unsplash/CC0 Public Domain Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF)....
Category: <span>Clinical Practice</span>
Post
Clinical practice guideline updated for migraine, tension-type headache
by Elana Gotkine In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of Internal Medicine, updated recommendations are presented for the management of migraine and tension-type headache (TTH). Noting that the 2020 U.S. Department of Veterans Affairs and U.S. Department...
Post
‘Do no harm’ is hurting 400 million long Covid patients worldwide
Almost five years since the pandemic began, there is not a single FDA-approved treatment An installation of 300 cots in front of the Washington Monument on May 12, 2023, representing the millions of people suffering from long Covid and myalgic encephalomyelitis/chronic fatigue syndrome.Andrew Harnik/AP By Julia Moore Vogel and Charlie McCone Oct. 24, 2024 Moore Vogel is a...
Post
How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics
Thought LeadersSusan MagsamenFounder & Director, The International Arts + Mind LabJohns Hopkins University School of Medicine NewsMedical spoke with Susan Magsamen, Executive Director of the International Arts + Mind Lab at Johns Hopkins University, during SfN 2024. In this interview, Susan shares insights into her groundbreaking work in neuroaesthetics, discussing how the arts can measurably...
Post
Montelukast doesn’t cut time to COVID symptom relief, clinical trial finds
by Mary Van Beusekom, University of Minnesota Credit: JESHOOTS.com from Pexels A 14-day course of the oral anti-inflammatory drug montelukast didn’t shorten symptom duration in nonhospitalized US adults with mild or moderate COVID-19, finds a randomized controlled clinical trial published today in JAMA Network Open. The Accelerating COVID-19 Therapeutic Interventions and Vaccines-6 (ACTIV-6) Study Group and Investigators randomly assigned...
Post
Amazon One Medical launches new AI tools one day after Cleveland Clinic announcement
Just one day after announcing an alliance with Cleveland Clinic, One Medical is launching new AI tools within its EHR to reduce administrative tasks for doctors. By Jessica Hagen October 22, 2024 03:31 pm Share 3668 Photo: John Fedele/Getty Images Amazon’s hybrid primary care provider One Medical announced the launch of new AI tools to help ease its providers’...
Post
Controlling Six Risk Factors Can Combat CKD in Obesity
TOPLINE: Optimal management of blood pressure, A1c levels, low-density lipoprotein cholesterol (LDL-C), albuminuria, smoking, and physical activity may reduce the excess risk for chronic kidney disease (CKD) typically linked to obesity. The protective effect is more pronounced in men, in those with lower healthy food scores, and in users of diabetes medication. METHODOLOGY: TAKEAWAY: IN...
Post
Just Call It ‘Chronic Rhinitis’ and Reach for These Treatments
Matthew F. Watto, MD: I’m Dr Matthew Frank Watto, here with my great friend and America’s primary care physician, Dr Paul Nelson Williams. Paul, are you ready to talk about rhinitis? Paul N. Williams, MD: I’m excited. It’s always the season to talk about rhinitis. Watto: We had a great guest for this podcast, Rhinitis and Environmental Allergies with...
Post
Empagliflozin offers lasting cardiorenal benefit in CKD patients
by Elana Gotkine Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic kidney disease at risk for progression, according to a study published online Oct. 25 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, held from...
Post
Magnetic field applied to both sides of brain shows rapid improvement for depression
University of Cambridge A type of therapy that involves applying a magnetic field to both sides of the brain has been shown to be effective at rapidly treating depression in patients for whom standard treatments have been ineffective. The treatment – known as repetitive transcranial magnetic stimulation (TMS) – involves placing an electromagnetic coil against...